Norris Medicines Limited (BOM:524414)

Market Cap	143.61M -41.7%
Revenue (ttm)	72.84M +76.5%
Net Income	-15.39M
EPS	-1.55
Shares Out	10.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	979
Average Volume	1,172
Open	13.50
Previous Close	14.25
Day's Range	13.01 - 14.75
52-Week Range	12.50 - 22.10
Beta	-0.91
RSI	46.58
Earnings Date	Feb 10, 2026

About Norris Medicines

Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exp...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 33
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524414

Financial Performance

In fiscal year 2025, Norris Medicines's revenue was 58.20 million, an increase of 3.27% compared to the previous year's 56.36 million. Losses were -12.37 million, 4.28% more than in 2024.